Surfactant and the neonatal lung

Hospital Medicine

Volumn 58, Issue 8, 1997, Pages 381-384

  Gibson, Alan T ^a  

^a JESSOP HOSPITAL FOR WOMEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT; SURFACTANT;

ARTICLE; CLINICAL PROTOCOL; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; HUMAN; MALE; METABOLISM; MORTALITY; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; RANDOMIZED CONTROLLED TRIAL;

CLINICAL PROTOCOLS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; INFANT, NEWBORN; MALE; PULMONARY SURFACTANTS; RANDOMIZED CONTROLLED TRIALS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SURFACE-ACTIVE AGENTS;

EID: 0031572386     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Benson BJ (1993) Genetically engineered human pulmonary surfactant. Clin Perinatol 20: 791-812
2. Courtney SE, Long W, McMillan D et al (1995) Double-blind 1-year follow-up of 1540 infants with respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air in four clinical trials. J Pediatrics 126: S43-S52
3. Egberts J (1992) Estimated costs of different treatments of the respiratory distress syndrome in a large cohort of preterm infants of less than 30 weeks of gestation. Biol Neonate 61: 59-65
4. Egberts J, de Winter JP, Sedin G et al (1993) Comparison of prophylaxis and rescue treatment with Curosurf in neonates less than 30 weeks' gestation: a randomized trial. Pediatrics 92: 768-74
5. Halliday HL (1996) Natural vs synthetic surfactants in neonatal respiratory distress syndrome. Drugs 51: 226-37
6. Holm BA, Waring AJ (1993) Designer surfactants: the next generation in surfactant replacement. Clin Perinatol 20: 813-30
7. Horbar JD, Wright EC, Onstad L (1993) Decreasing mortality associated with the introduction of surfactant therapy: an observational study of neonates weighing 601 to 1300 grams at birth. Pediatrics 82: 191-6
8. Jobe AH (1993) Pulmonary surfactant therapy. N Engl J Med 328: 861-8
9. Jobe AH, Mitchell BR, Gunkel JH (1993) Beneficial effects of the combined use of prenatal corticosteroids and postnatal surfactant on preterm infants. Am J Obstet Gynecol 168: 508-13
10. Kattwinkel J, Bloom BT, Delmore P et al (1993) Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation. Pediatrics 92: 90-8
11. Kendig JW, Notter RH, Cox C et al (1991) A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation. N Engl J Med 324: 865-71
12. Long W (1993) Synthetic surfactant. Sem Perinatol 17: 275-84
13. Obladen M (1992) History of surfactant research. In: Robertson B, Van Golde LMG, Batenburg JJ, eds. Pulmonary Surfactant from Molecular Biology to Clinical Practice. Elsevier, Amsterdam: 1-18
14. Spafford PS, Kendig JW, Maniscalco WM (1993) Use of natural surfactants to prevent and treat respiratory distress syndrome. Sem Perinatol 17: 285-94
15. Speer CP, Halliday HL (1994) Surfactant therapy in the newborn. Current Paediatrics 4: 5-9
16. The Osiris Collaborative Group (1992) Early vs delayed neonatal administration of a synthetic surfactant - the judgment of Osiris. Lancet 340: 1363-9
17. Tubman TRJ, Halliday HL, Normand C (1991) Economic impact of porcine surfactant replacement (Curosurf) for severe neonatal respiratory distress syndrome. J Perinatal Med 19: 403-7
18. Walti H, Paris-Llado J, Breart G, Couchard M (1994) Porcine surfactant replacement therapy in newborns of 25-31 weeks' gestation: a randomized, multicentre trial of prophylaxis vs rescue with multiple low doses. Acta Paediatr 84: 913-21